NOVADIP Biosciences

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip’s mission is to provide innovative solutions for patients with limited or no effective treatment options.
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Belgium
Year Founded:
2013
Main Therapeutic Focus:
Lead Product in Development:
autologous bone tissue engineered product for orphan indication of critical size bone defect
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3-4
Speaker
photo
CEO
NOVADIP Biosciences